121 results
8-K
EX-99.1
np10izdkcf3z2n26f
25 Mar 24
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
4:05pm
8-K
EX-10.1
4ougemlk
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
424B7
itf0 v8vybvd6lq8uuyk
15 Mar 24
Prospectus with selling stockholder info
3:53pm
8-K
EX-4.1
7ccuutzhgpeio
5 Dec 23
Fennec Announces Incremental $5 Million Investment from Petrichor
8:51pm
424B3
6t6sknvrtdj
15 Dec 22
Prospectus supplement
5:12pm